Abstract
Aim
To evaluate clinicopathological features and optimal management of Sertoli–Leydig cell tumours (SLCTs) of ovary.
Method
A retrospective observational analysis of patients with histopathological diagnosis of SLCT of ovary attending VPS Lakeshore Global Lifecare, Kochi, Kerala, between 2003 and 2018 was done.
Results
During the study period, a total of six cases of SLCT of ovary were identified. Mean age was 26 years (8–47). The most common mode of presentation was abdominal pain in three (50%) cases. Clinically palpable mass was present in all the cases. The average maximum diameter of the ovarian mass was 14.9 cm (10.4–22 cm). Ultrasound scan showed unilateral solid cystic lesion with an increased vascularity in all the cases. Frozen section was done in two (33%) patients in view of patients’ desire for fertility-sparing surgery. Total abdominal hysterectomy with bilateral salpingo oophorectomy, omentectomy and bilateral pelvic lymph node dissection was done in four (66%) patients. The remaining two (33%) patients underwent unilateral salpingo oophorectomy in view of young age. One (17%) patient had well-differentiated histology, two (33%) patients had poorly differentiated histology, while three (50%) had intermediate-differentiated histology. Two (33%) patients received adjuvant chemotherapy. One patient had pelvic recurrence.
Conclusion
SLCTs are rare ovarian tumours with low malignant potential. Most of these cases are unilateral and present in stage I. Extra ovarian spread and lymph node involvement are rare in SLCTs. Young females can be treated with fertility-sparing surgery. However, owing to the rarity of the tumour and limited research data, there are no standard treatment guidelines.
This is a preview of subscription content,
to check access.References
Gui T, Cao D, Shen K, Yang J, Zhang Y, Yu Q, et al. A clinicopathological analysis of 40 cases of ovarian Sertoli–Leydig cell tumors. Gynecol Oncol. 2012;127:384–9.
Young RH, Scully RE. Ovarian Sertoli–Leydig cell tumours. A clinicopathological analysis of 207 cases. Am J Surg Pathol. 1985;9:543–69.
Young RH, Scully RE. Sex cord-stromal, steroid cell, and other ovarian tumors. In: Kurman RJ, editor. Blaustein’s pathology of female genital tract. 5th ed. New York: Springer; 2002. p. 929.
Alam K, Maheshwari V, Rashid S, et al. Bilateral Sertoli–Leydig cell tumor of the ovary: a rare case report. Indian J Pathol Microbiol. 2009;52:97–9.
Zaloudek C, Norris H. Sertoli–Leydig cell tumors of the ovary. A clinicopathological study of 64 intermediate and poorly differentiated neoplasms. Am J Surg Pathol. 1984;8:405–18.
Caringella A, Loizzi V, Resta L, Ferreri R, Loverro G. A case of Sertoli–Leydig cell tumor in a postmenopausal woman. Int J Gynecol Cancer. 2006;16:435–8.
Colombo N, Parma G, Zanagnolo V, Insinga A. Management of ovarian stromal cell tumors. J Clin Oncol. 2007;25:2944–51.
Wilkinson N, Osborn S, Youngh RH. Sex cord-stromal tumours of the ovary: a review highlighting recent advances. Diagn Histopathol. 2008;14:388–400.
Xiao H, Li B, Zuo J, et al. Ovarian Sertoli–Leydig cell tumor: a report of seven cases and a review of the literature. Gynecol Endocrinol. 2013;29:192–5.
Akman L, Ertas IE, Gokcu M, et al. Ovarian Sertoli–Leydig cell tumors: a multicenter long-term clinicopathological analysis of 27 patients. J Can Res Ther. 2016;12:290–4.
Bhat RA, Lim YK, Chia YN, Yam KL. Sertoli–Leydig cell tumor of the ovary: analysis of a single institution database. Obstet Gynecol Res. 2012;39:305–10.
Gómez-Peñaloza C, Cañavera-Constantino A, Aristi-Urista G. Bilateral metachronic ovarian Sertoli–Leydig cell tumour in an 11-year-old patient: a case report. Rev Med Hosp Gen Mex. 2018;81(3):139–45.
Dicker D, Dekel A, Feldberg D, et al. Bilateral Sertoli–Leydig cell tumor with heterologous elements: report of an unusual case and review of the literature. Eur J Obstet Gynecol Reprod Biol. 1986;22:175–81.
Zhang M, Cheung MK, Shin JY, Kapp DS, Husain A, Teng NN, et al. Prognostic factors responsible for survival in sex cord stromal tumors of the ovary—an analysis of 376 women. Gynecol Oncol. 2007;104:396–400.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that they have no conflict of interest.
Informed Consent
This is a retrospective study done in already available hospital data records.
Ethics Statement
The need for ethical approval was waived due to retrospective nature of analysis. All data were anonymized before analysis. The study was performed in accordance with ethical standards laid down in 1964 declaration of Helsinki and its later amendments.
Human and Animal Rights Statement
This is a retrospective observational study. There was no direct involvement or intervention done to the patient during the study period from the author side.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Abdul Shukur, R., Keshav, C., Puzhakkal, S. et al. Clinicopathological Features and Optimal Management of Sertoli–Leydig Cell Tumours of Ovary: A Retrospective Observational Study of Six Cases. Indian J Gynecol Oncolog 18, 7 (2020). https://doi.org/10.1007/s40944-019-0352-8
Received:
Revised:
Accepted:
Published:
DOI: https://doi.org/10.1007/s40944-019-0352-8